How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

192 results for


Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. (PubMed)

selection strategies were obesity, induction/augmentation of labor, twins, hydramnios, anemia, and arrest of descent. Amnioinfusion appeared to be protective against uterine atony (OR, 0.53; 95% CI, 0.29-0.98).Independent risk factors for uterine atony requiring treatment include Hispanic and non-Hispanic white ethnicity, preeclampsia, and chorioamnionitis.Copyright © 2013 Mosby, Inc. All rights reserved.

Full Text available with Trip Pro

2013 American journal of obstetrics and gynecology Controlled trial quality: predicted high

102. Interventions for helping to turn term breech babies to head first presentation when using external cephalic version. (PubMed)

assess interventions such as tocolysis, fetal acoustic stimulation, regional analgesia, transabdominal amnioinfusion or systemic opioids on ECV for a breech baby at term.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2011) and the reference lists of identified studies.Randomised and quasi-randomised trials comparing the above interventions with no intervention or other methods to facilitate ECV at term.We assessed eligibility and trial quality. Two review (...) 0.51 to 0.89, six studies, 550 women) but there was no difference identified in cephalic presentation in labour (average RR 1.63, 95% CI 0.75 to 3.53, three studies, 279 women) nor in caesarean sections (average RR 0.74, 95% CI 0.40 to 1.37, three studies, 279 women) or fetal bradycardia (average RR 1.48, 95% CI 0.62 to 3.57, two studies, 210 women).There were insufficient data on the use of vibroacoustic stimulation, amnioinfusion or systemic opioids.Betastimulants, to facilitate ECV, increased

Full Text available with Trip Pro

2012 Cochrane database of systematic reviews (Online)

103. Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

) syndrome, other end-organ affliction or Central Nervous System (CNS) findings other than mild headache; Fetal malpresentation; Diagnosed congenital anomalies, not including polydactyly; Any evidence of fetal compromise at baseline (e.g., non-reassuring fetal heart rate pattern or meconium staining); Amnioinfusion or other treatment of non-reassuring fetal status at any time prior to the induction attempt; Ruptured membranes ≥ 48 hours prior to the start of treatment; Suspected chorioamnionitis; Fever

2011 Clinical Trials

104. Kidney

in case of kidney failure. . Failure of one kidney to form occurs in approximately one in 750 live births. Failure of both kidneys to form used to be fatal; however, medical advances such as amnioinfusion therapy during pregnancy and peritoneal dialysis have made it possible to stay alive until a transplant can occur. Unilateral small kidney occurs in approximately one in every 2400 live births Ureteropelvic Junction Obstruction or UPJO; although most cases are congenital, some are acquired. Diagnosis

Full Text available with Trip Pro

2012 Wikipedia

105. Lactated Ringer's Solution in Neonates With Feeding Intolerance

to achieve adequate enteral nutrition as soon as possible. Because LR is a an amniotic fluid-like solution, it may improve gastro-intestinal function and avoid fasting, as well as its multiple problems (e.g. intestinal atrophy and decreased intestinal motility). LR was chosen as the test solution because of experience documenting its safe use in comparable groups: in newborn resuscitation parenterally, in amnioinfusion, and in bowel irrigation. Moreover, LR is similar in electrolytes composition

2010 Clinical Trials

106. Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

pooling in the vagina after amnioinfusion; or visible leakage of amniotic fluid from the cervix) B. Rupture of the membranes in the presence of more than 6 contractions per hour or cervical dilation of 3 cm or more, unless oxytocin was withheld for at least 12 hours (other induction agents allowed) C. Chorioamnionitis - exclude if patient is diagnosed with chorioamnionitis D. Cervical dilation ≥ 8 cm E. Evidence of non-reassuring fetal status requiring immediate delivery Participation in another

2010 Clinical Trials

107. Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery

fetal heart rate pattern or meconium staining); Amnioinfusion or other treatment of non-reassuring fetal status at any time prior to the induction attempt; Ruptured membranes ≥ 48 hours prior to the start of treatment; Suspected chorioamnionitis; Fever (oral or aural temperature > 37.5°C); Any condition in which vaginal delivery is contraindicated e.g., placenta previa or any unexplained genital bleeding at any time after 24 weeks during this pregnancy; Known or suspected allergy to misoprostol

2010 Clinical Trials

108. Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs. bipolar cord coagulation. (PubMed)

who had undergone RFA, in a 2 : 1 ratio, controlling for gestational age and indication. The primary outcome was fetal survival.Twenty patients in the RFA group were matched with 40 patients in the BPC group. Fewer additional intra-operative procedures were performed in the RFA group compared with the BPC group: amnioinfusion, 10% vs. 75%, respectively (P < 0.01); and amnioreduction, 5% vs. 40%, respectively (P = 0.004). The overall survival rates were 87.5% in the RFA group and 88% in the BPC

Full Text available with Trip Pro

2010 Ultrasound in Obstetrics and Gynecology

109. Risk factors for early and late onset of respiratory symptoms in babies born through meconium. (PubMed)

of amnioinfusion (AI) for the prevention of MAS among women with thick-consistency MSAF. MAS was defined as onset of respiratory distress requiring oxygen supplementation within the first 4 hours of life. Patients with respiratory symptoms with onset at >or=4 hours were treated as a separate outcome category, "late-onset respiratory distress." We developed peripartum and intrapartum regression models to identify the risk of MAS and its subgroups. A tracing with marked abnormalities was a significant risk

2010 American journal of perinatology Controlled trial quality: uncertain

110. Mifepristone in second-trimester medical abortion: a randomized controlled trial. (PubMed)

of digoxin amnioinfusion, participants received a randomly allocated, identical-appearing capsule containing either mifepristone, 200 mg, or placebo. Patients returned the following day for induction with buccal misoprostol. The primary outcome was the time interval from the first misoprostol dose to abortion. Analysis utilized survival curves with log-rank testing. RESULTS: Of 64 women, 32 received mifepristone and 32 received placebo. The groups did not differ by ethnicity, age, parity, reason

Full Text available with Trip Pro

2008 EvidenceUpdates Controlled trial quality: predicted high

111. Reducing stillbirths: interventions during labour. (PubMed)

not demonstrated impact on perinatal mortality. There was limited evidence of impact for maternal hyperoxygenation, and concerns remain about maternal safety. Transcervical amnioinfusion for meconium staining appears promising for low/middle income-country application according to the findings of many small studies, but a large randomised trial of the intervention had no significant impact on perinatal mortality, suggesting that further studies are needed.Although the global appeal to prioritise access (...) to emergency obstetric care, especially vacuum extraction and Caesarean section, rests largely on observational and population-based data, these interventions are clearly life-saving in many cases of fetal compromise. Safe, comprehensive essential and emergency obstetric care is particularly needed, and can make the greatest impact on stillbirth rates, in low-resource settings. Other advanced interventions such as amnioinfusion and hyperoxygenation may reduce perinatal mortality, but concerns about safety

Full Text available with Trip Pro

2009 BMC pregnancy and childbirth

112. Amnioinfusion Initiative

Amnioinfusion Initiative Amnioinfusion Initiative - Full Text View - Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Amnioinfusion Initiative The safety and scientific validity of this study is the responsibility of the study (...) by: Università degli Studi di Brescia Study Details Study Description Go to Brief Summary: The aim of this study is to compare perinatal survival in patients presenting with early spontaneous PPROM and persistent oligohydramnios, managed either conservatively or with serial amnioinfusions. Condition or disease Intervention/treatment Phase Oligohydramnios Procedure: amnioinfusion Phase 3 Detailed Description: Early spontaneous Preterm Premature Rupture of Membranes (PPROM) is associated with high perinatal

2008 Clinical Trials

113. Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials. (PubMed)

Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials. 18190380 2008 02 07 2008 01 14 1471-0528 115 3 2008 Feb BJOG : an international journal of obstetrics and gynaecology BJOG Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials. 409-10; author reply 410 10.1111/j.1471-0528.2007.01600.x Sanchez-Ramos L L eng Comment Letter England BJOG 100935741 1470-0328 AIM IM BJOG

Full Text available with Trip Pro

2008 BJOG

114. Abnormal fetal heart rate tracing patterns in patients with thick meconium staining of the amniotic fluid: association with perinatal outcomes. (PubMed)

Abnormal fetal heart rate tracing patterns in patients with thick meconium staining of the amniotic fluid: association with perinatal outcomes. The objective of the study was to evaluate, in labors complicated by thick meconium-stained amniotic fluid, the association between specific fetal heart rate (FHR) patterns and adverse perinatal outcomes.A retrospective cohort study of patients with FHR tracing data (n = 1638) from a previously reported randomized controlled trial of amnioinfusion

2008 American Journal of Obstetrics and Gynecology

115. Premature Rupture of Membranes

:i134-43. doi: 10.1093/ije/dyq030. ; Royal College of Obstretricians and Gynaecologists (2012) ; Amnioinfusion for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2011 Dec 7(12):CD000942. doi: 10.1002/14651858.CD000942.pub2. ; Royal College of Obstetricians and Gynaecologists (October 2010) ; Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev

2008 Mentor

116. Oligohydramnios

, the gestational age, the inducibility of the mother's cervix and the severity of the oligohydramnios. After term : Isolated oligohydramnios in the post-term patient has no greater risk for caesarean delivery and there is insufficient evidence to support induction for women with oligohydramnios. [ , ] The treatment of maternal dehydration with oral or intravenous rehydration has been shown to increase the AFV by 30%. [ ] Amnioinfusion Increasing the amount of fluid within the amniotic cavity can (...) be accomplished with the use of amnioinfusion. In this process, sodium chloride or Ringer's lactate is infused under ultrasound guidance via a needle inserted through the uterine wall. The current evidence on the safety and efficacy of this procedure means it is only undertaken in the UK under special arrangements that include audit and research. [ ] Amnioinfusion can also be undertaken during labour transcervically via an intrauterine catheter. However, The Royal College of Obstetricians and Gynaecologists

2008 Mentor

117. Fetal Distress

that very short 'decision-to-incision' time (<20 minutes) may be inversely proportional to neonatal outcomes, ie lower umbilical pH and Apgar scores [ ] . Amnioinfusion has been shown to be beneficial in suspected umbilical cord compression (particularly when there is oligohydramnios), with a reduced risk of caesarean section [ ] : In this process, sodium chloride or Ringer's lactate is infused transcervically or, if the membranes are still intact, via a needle inserted under ultrasound guidance through (...) pneumonitis if inhaled: Significant meconium is defined as dark green or black amniotic fluid that is thick or tenacious, or any meconium-stained amniotic fluid containing lumps of meconium [ ] : If significant meconium is present, fetal blood sampling and advanced neonatal life support may be required at delivery. If there has been non-significant meconium, the baby should be observed at one and two hours. Amnioinfusion has been used to reduce the risk of meconium aspiration by diluting the meconium

2008 Mentor

118. Post Term Pregnancy

assessment with electronic fetal monitoring (EFM) is recommended. If meconium and variable decelerations are present, then consider amnioinfusion. If the woman has meconium stained liquor and a non-reassuring EFM tracing and is in a facility without operating room (OR) capability, then transfer to a facility with OR capability should be considered. Be prepared for shoulder dystocia and neonatal resuscitation at delivery (See Newborn Guideline 7: Newborn Resuscitation, Resources and Education). REFERENCES

2005 British Columbia Perinatal Health Program

119. Local Anesthesia and Pain Perception During an Amniocentesis

between the ages of 18 and 45 years Gestational ages 15 - 24 weeks Exclusion Criteria: Multiple gestation Refusal to participate in the trial Known hypersensitivity to lidocaine Amniocentesis during this pregnancy Amnioinfusion/amnioreduction where the procedure is likely to be prolonged Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided

2007 Clinical Trials

120. Four-dimensional ultrasound guidance of prenatal invasive procedures. (PubMed)

Four-dimensional ultrasound guidance of prenatal invasive procedures. Technological advances in ultrasonography have revolutionized prenatal diagnosis and treatment. Here we evaluate the effectiveness of using four-dimensional (4D) ultrasonography to guide prenatal invasive procedures.Prenatal invasive procedures using 4D ultrasound were recorded prospectively in 93 cases: 10 amnioinfusions, 50 amniocenteses, 8 chorionic villus samplings (CVS) and 25 cordocenteses. The needle target site

Full Text available with Trip Pro

2005 Ultrasound in Obstetrics and Gynecology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>